Clinical and molecular genetics of thyroid cancer;Klinische und molekulare genetik des schilddrüsenkarzinoms

Onkologe

Volumn 11, Issue 1, 2005, Pages 20-28

  Karges, W ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Genotype; Mutation; Oncogene; Phenotype; Thyroid cancer

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN RET; TRANSCRIPTION FACTOR PAX8;

ARTICLE; CHROMOSOME REARRANGEMENT; FAMILIAL CANCER; FOLLICULAR CARCINOMA; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HUMAN; MOLECULAR GENETICS; ONCOGENE; PAPILLARY CARCINOMA; PHENOTYPE; PROPHYLAXIS; RADIATION EXPOSURE; THYROID CARCINOMA; THYROIDECTOMY;

EID: 13644264813     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-004-0812-2     Document Type: Article

References (28)

1. Tallini G (2002) Molecular pathobiology of thyroid neoplasms. Endocr Pathol 13:271-288
2. Alberti L, Carniti C, Miranda C, Roccato E, Pierotti MA (2003) RET and NTRK1 proto-oncogenes in human diseases. J Cell Physiol 195:168-186
3. Gimm O (2001) Thyroid cancer. Cancer Lett 163:143-156
4. Kim DS, McCabe CJ, Buchanan MA, Watkinson JC (2003) Oncogenes in thyroid cancer. Clin Otolaryngol 28:386-395
5. Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3-16
6. Hunt JL (2002) Molecular mutations in thyroid carcinogenesis. Am J Clin Pathol 118 [Suppl]:S116-127
7. Fagin JA (2002) Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16:903-911
8. Malchoff CD, Malchoff DM (2002) The genetics of hereditary nonmedullary thyroid carcinoma. J Clin Endocrinol Metab 87:2455-2459
9. Corvilain B, Van-Sande J, Dumont JE, Vassart G (2001) Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55:143-158
10. Jhiang SM, Cho JY, Furminger TL et al. (1998) Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res 154:265-270
11. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE (2000) Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290:138-141
12. Kroll TG, Sarraf P, Pecciarini L et al. (2000) PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289:1357-1360
13. Wiseman SM, Loree TR, Rigual NR et al. (2003) Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 25:662-670
14. Lam KY, Lo CY, Chan KW, Wan KY (2000) Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329-338
15. Karges W, Dralle H, Raue F et al. (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52-58
16. Eng C (1999) RET proto-oncogene in the development of human cancer. J Clin Oncol 17:380-393
17. Ludwig L, Kessler H, Wagner M et al. (2001) Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation. Cancer Res 61:4526-4535
18. Eng C, Clayton D, Schuffenecker I et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. Jama 276:1575-1579
19. Niccoli-Sire P, Murat A, Rohmer V et al. (2001) Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. J Clin Endocrinol Metab 86:3746-3753
20. Frank-Raue K, Hoppner W, Frilling A et al. (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81:1780-1783
21. Machens A, Gimm O, Hinze R, Hoppner W, Boehm BO, Dralle H (2001) Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J Clin Endocrinol Metab 86:1104-1109
22. Machens A, Niccoli-Sire P, Hoegel J et al. (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517-1525
23. Alsanea O (2000) Familial nonmedullary thyroid cancer. Curr Treat Options Oncol 1:345-351
24. Lesueur F, Stark M, Tocco T et al. (1999) Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84:2157-2162
25. Brandi ML, Gagel RF, Angeli A et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
26. Frilling A, Weber F, Tecklenborg C, Broelsch CE (2003) Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene. Langenbecks Arch Surg 388:17-26
27. Lips CJ, Hoppener JW, Thijssen JH (2001) Medullary thyroid carcinoma: role of genetic testing and calcitonin measurement. Ann Clin Biochem 38:168-179
28. Anonymous (1998) Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Dtsch Artzebl 95:1121-1127